Correlations of QOL questionnaire results and effects of leukotriene receptor antagonist in asthma and allergic rhinitis Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006
Clinical efficacy of leukotriene antagonist in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005
A prospective study of asthma and rhinitis interrelationships with reference to the incidence of eczema and the use of leukotreine receptor antagonists Source: Eur Respir J 2001; 18: Suppl. 33, 200s Year: 2001
Additional overall benefit to coexistent asthma and rhinitis symptoms control in patients treated with leukotriene receptor antagonist Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
The effect of a leukotriene antagonist, pranlukast, on allergen-induced airway responses and circulating dendritic cells in subjects with atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 414s Year: 2003
The CysLT1 receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 121s Year: 2006
Effects of loratadine and its generic on symptoms of asthma and rhinitis Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008
Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016
Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Presence of rhinitis modulates the effect of asthma Source: Annual Congress 2009 - Epidemiology of atopy and asthma Year: 2009
Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
The effect of cockroach-sensitivity on allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 436s Year: 2001
Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 Source: Eur Respir J 2013; 41: 46-52 Year: 2013
Impact of allergic rhinitis on asthma Source: Annual Congress 2012 - PG6 Hot topics in paediatric allergy Year: 2012